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ABSTRACT
The demand for antimicrobial peptides (AMPs) is
rising because of the increased occurrence of
pathogens that are tolerant or resistant to conven-
tional antibiotics. Since naturally occurring AMPs
could serve as templates for the development of
new anti-infectious agents to which pathogens are
not resistant, a resource that contains relevant in-
formation on AMP is of great interest. To that extent,
we developed the Dragon Antimicrobial Peptide
Database (DAMPD, http://apps.sanbi.ac.za/dampd)
that contains 1232 manually curated AMPs.
DAMPD is an update and a replacement of the
ANTIMIC database. In DAMPD an integrated inter-
face allows in a simple fashion querying based on
taxonomy, species, AMP family, citation, keywords
and a combination of search terms and fields
(Advanced Search). A number of tools such as
Blast, ClustalW, HMMER, Hydrocalculator,
SignalP, AMP predictor, as well as a number of
other resources that provide additional information
about the results are also provided and integrated
into DAMPD to augment biological analysis of
AMPs.
INTRODUCTION
Antimicrobial peptides (AMPs) are recognized for their
signiﬁcant role in the innate immune response and are
found in bacteria, fungi, animals and plants (1–7). AMPs
are short [6–100 amino acid residues (8,9)] ribosomally-
produced peptides that are post-translationally activated
by proteolytic cleavage. With few exceptions, AMPs are
cationic and possess a signiﬁcant proportion (30%) of
hydrophobic residues (10,11). Their secondary structure
generally adopts one of four structural motifs: (i) an
a-helical structure, (ii) b-stranded structure due to the
presence of two or more disulﬁde bonds, (iii) b-hairpin
structure or loop due to the presence of a single disulﬁde
bond and/or cyclization of the peptide chain and (iv) an
extended structure (12). Mature AMPs form amphipathic
structures that associate via electrostatic interactions
between positively charged AMP regions and negatively
charged phospholipids of the cell membrane (4,14) which
is thought to be necessary for antimicrobial activity.
However, AMP modes of action can be divided into mem-
brane disruptive or non-disruptive categories (8,13–17)
indicating that multiple modes of action following
membrane association exist. In addition, mammalian
AMPs exhibit chemokine-like and immunomodulatory
activities (18,19) that can integrate innate and adaptive
immune responses to microbial infection. Measurements
of non-synonymous and synonymous mutation rates in
mammalian AMP exons and comparative genomic
studies indicate that mammalian AMP genes are under
positive selection and are among the most rapidly
evolving group of mammalian genes known (20). The com-
bination of a broad spectrum antimicrobial activities
targeted at non-protein cellular components with
localized, high-level expression at the site of infection,
makes AMPs highly effective antimicrobial agents with
signiﬁcant potential as a source of new antimicrobial
drugs (21) such as new more effective antitubercular
agents active against multidrug resistant (MDR) and ex-
tensively drug resistant (XDR) Mycobacterium tuberculosis
complex pathogens (22).
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APD (23), AMSdb (14), BACTIBASE (24), Defensin
knowledgebase (25), PenBase (26), Peptaibol Database
(27), SAPD (28), AMPer (29), CyBase (30), BAGEL




PhytAMP (33) and RAPD (34), each has certain short-
comings, such as covering only speciﬁc AMP families or
containing a limited collection of AMP families; many are
lacking manually curated AMPs or do not have tools for
exploration of relevant AMP characteristics (detailed in
Supplementary Table S1, in Section 5).
These observations combined with a frequent update of
peptide information in major (http://apps.sanbi.ac.za/
dampd/Link.php) databases, motivated us to retrieve
peptides from UniProt (36) and GenBank (37), select
those that are AMPs based on manual curation and
develop a new database, Dragon Antimicrobial Peptide
Database (DAMPD) as an update and extension to our
earlier published ANTIMIC (35) database. DAMPD
contains information on UniProt reviewed and UniProt
non-reviewed (i.e. putative) natural AMPs. The utility of
DAMPD is enriched by integration of several tools such
as BLAST (38,39), ClustalW (40), HMMER (42),
Hydrocalculator (43), SignalP (44,45), AMP predictor,
as well as links to several resources that can provide add-
itional information on results generated by DAMPD and
used to explore characteristics of AMPs and enhance
search for novel AMPs thus supporting biological
analysis of AMPs.
POPULATION OF DATABASE
AMPs were retrieved from UniProt (search: Antimicrobial
[KW-0929]") AND (existence: evidence at protein
level OR existence: evidence at transcript level). On 9
September 2011 UniProt we retrieved 1483 (PE1) and
682 (PE2) peptides. We manually curated these entries
selecting only peptides that are experimentally validated.
This ﬁnally resulted in 1232 (out of 2165) manually
curated peptides that have experimentally proven/con-
ﬁrmed antimicrobial activity to be included into
DAMPD database. We used the latest information
on each of these 1232 peptides from UniProt and
re-build our latest database as a version ‘DAMPD
DB 09_Sep_2011 (1232)’. To populate DAMPD, we
searched for AMPs from different databases, as well as
from journals. If a database entry has a keyword
indicating the peptide has antimicrobial qualities, this
may be an assumption derived from sequence similarity.
Antimicrobial activity can be sensitive to even slight
changes in the peptide, and just one amino acid difference
can mean that the peptide is inactive. Since we only
wanted true AMPs, we checked the research articles
and made sure each peptide did in fact have an experimen-
tally proven antimicrobial activity. We also added in
peptides that UniProt has not yet annotated to be
antimicrobial. All annotations were veriﬁed from the
original articles.
DATABASE SYSTEM
DAMPD is the collection of manually curated AMPs. An
integrated system driven through MySql (5.0), PHP
(5.2.4), and Perl (Ver. 5.8.8) was developed to handle the
storage of information on these peptides. Each peptide in
DAMPD database has a unique accession number (e.g.
DAMPD:0001). AMPs in DAMPD include peptides con-
taining precursor (477 AMPs), as well as mature peptide
parts (755 AMPs). Peptide entries were cross-referenced to
external resources and linked to graphical views. This
section details on sub-databases, multiple catalogs, tools
and graphics views.
Sub-databases
AMPs are retrieved from UniProt where the entries are
categorized as reviewed and non-reviewed. Our 1232
AMPs are thus split into 1113 reviewed and 119
non-reviewed entries we named Swiss-Prot_AMP and
TrEMBL_AMP, respectively. They form two
sub-databases in DAMPD one with reviewed and the
other with non-reviewed UniProt AMPs. The total collec-
tion of these AMPs is termed as ‘UniProt_AMP’. We
could not get any new peptide (not already included in
the above) from GenBank. Consequently, DAMPD
contains all AMPs from UniProt and GenBank.
Multiple search capabilities
DAMPD has six search capabilities. These six search tools
can operate as independent search engines to interrogate
the database or executed as part of a more complex query.
Five of these search utilities are based on catalogs that are
created as vocabularies of terms from taxonomies, AMP
families, species, keywords, and citations of 1232 peptide
entries to ease browsing of the database.
Taxonomy catalog. Organisms are classiﬁed in a hierarch-
ical tree structure. Taxonomy database contains every
node (taxon) of the tree.
Species catalog. UniProt brings out annotation on species
on each peptide that we compiled into a catalog for
speciﬁc search by species.
Keyword catalog. UniProt entries are tagged with
keywords that can be used to retrieve particular subsets
of entries.
Family catalog. UniProt general annotation provides
the family details on each for known AMPs. We collected
family, super family, sub-family information and build
family catalog.
Citation catalog. UniProt keeps publications with title
(RT, example: protein interaction); author name (RA,
examples: Ashburner, Sanger F., Pierson L.S. III),
journal (RL, example: J. Exp. Biol.), year of publication
Nucleic Acids Research, 2012,Vol. 40,Database issue D1109(YR, example: 1951) are cataloged for search on any of
them.
Advanced search. This search category allows a combin-
ation of search terms, search ﬁelds and search values.
Users can query the database using ﬁeld names which
are not listed in the other catalogs.
Tools and resources
Several analytical tools and relevant resources are
integrated into DAMPD to support exploration and bio-
logical analysis of AMPs (http://apps.sanbi.ac.za/dampd/
BioTools.php). For the same purpose we provided links to
a number of additional resources.
Standalone version of integrated tools. The DAMPD
database tools can also operate on a standalone basis.
For example, one can perform an alignment of antimicro-
bial sequences or any other protein/DNA sequence using
ClustalW (40). NJplot (41) is used to draw phylogenetic
tree of the aligned sequence generated by ClustalW (40).
HMMER (42) allows the user to tentatively classify
unknown sequences into a particular antimicrobial
family using two ways: (i) the user can either use 27 pre-
deﬁned antimicrobial libraries of proﬁles or (ii) use their
own generated proﬁles. The physiochemical properties of
the peptides such as hydrophobicity, net charge, percent-
age of hydrophobic residues, mean hydrophobicity and
mean hydrophobic moment can be calculated using the
Hydrocalculator (43). Hydrophobicity of amino acid
residues inﬂuences protein folding, protein subunits inter-
actions binding to receptors and interactions of proteins
with cell membranes (43). Hydrophobic moment of a
sequence gives an indication as to how the hydrophobi-
city’s of its constituent residues of a particular segment of
the sequences happen to be folded into a particular con-
formation, i.e. a-helix and b-helix. SignalP (44,45) can be
used to predict the signal cleavage site of the peptide from
different organisms. This is useful is determine the mature
part of the peptide that has the activity.
Catalog-integrated tools. Each catalog page contains
integrated tools such as BLAST, ClustalW, HMMER
and Hydrocalculator and SignalP. When the user
performs a search, the result page shows the summary of
peptide information. The user can choose to process the
entire result set or select individual sequences from the
result set. The integrated tools are implemented in this
framework.
Other resources. The retrieved peptides in DAMPD
searches can be linked to other databases to provide add-
itional information on these peptides. These resources are
described here: ProtParam (46) computes the
physico-chemical properties of a sequence. Compute Pl/
MW (47,48) requires the user to choose or enter a
Swiss-Prot/TrEMBL accession number. ProtScale (46)
generates a proﬁle of each type of amino acid on a
protein. PeptideMass (46,49) uses a Swiss-Prot/TrEMBL
accession number assigned to a protein to generate peptide
information. PeptideCutter (46) requires the end user to
enter an accession number used by Swiss-Prot/TrEMBL
to uniquely identify proteins. ModBase (50) provides pre-
dicted protein structure models. SMART (51) a Simple
Modular Architecture Research Tool maps a protein
sequence to its catalog of target domains. InterProt (52)
uses a host of member databases to generate protein sig-
natures, which are used as a basis to identify distant rela-
tionships between potentially novel sequences. Pfam (53)
is a database of protein family classiﬁcation, protein
domain data and multiple sequence alignments generated
using Hidden Markov models. Prosite (54) is a database,
which contains descriptions and documentation relating
to amino acid proﬁles, protein domains, families and func-
tional sites. ProtoNet (55) is a database of computation-
ally derived protein structures, which have been clustered
and then hierarchically structured using data, derived
from Swiss-Prot/TrEMBL.
DAMPD VERSUS ANTIMIC
We transformed and upgraded the ANTIMIC database
which contained 1799 peptides from UniProt and
Gen-Bank, to DAMPD resource. DAMPD is aimed to
be one stop web portal user system for AMPs. The
capabilities of DAMPD are enriched with several tools
that can enhance AMP studies. One of these is the AMP
predictor (based on support vector machines, SVM) that
can classify very accurately a peptide into a family of
AMPs (out of 27 AMP families), a feature that currently
no other tool and database has. Users can search the DB
either for ‘Reviewed’ or ‘Non-Reviewed’, or both classes
of peptides. Catalogs help user to search database differ-
ently through various aspects like ‘Keywords, Taxonomy,
Citations, Family and Species’. The system is capable of
updates with the latest information on 1232 peptides
whenever these UniProt entries are updated. ‘Help’
pages are provided to give explanations on the use and
access to the database. ‘Links to other antimicrobial data-
bases’ provide direct access to information from other
relevant AMP resources. We further enabled users to
view the results of their queries either on their computer
screen or to receive them by email. We regularly download
all peptides with ‘keyword: antimicrobial’ from UniProt
and GenBank, manually verify them as explained earlier
and add only those peptide entries which are experimen-
tally validated.
DAMPD VERSUS OTHER AMP DATABASES
Supplementary Table 1 provides a short comparison of
DAMPD and currently available AMP databases and re-
sources. Signiﬁcant improvements available in DAMPD
include the combination of BLAST, ClustalW,
Hydrocalulator, SignalP, AMP prediction using
HMMER and SVM-based predictor of AMPs operating
on a database of experimentally validated peptides. These
features are combined with multilevel catalog searching.
The current DAMPD version has 145 entry keyword
catalog entries, 943 taxonomy catalog entries. The AMP
family catalog has main and sub families of 128 entries,
and the species catalog possess 406 entries.
D1110 Nucleic AcidsResearch, 2012,Vol. 40,Database issueCONCLUSION
Most of the other ‘antimicrobial’ databases to date are
becoming outdated and not regularly maintained.
We integrated retrieving, creation of catalogs, database
version as semi-automatic process which helps us in
updating DAMPD within a day. This process automatic-
ally retrieved the new peptides of ‘antimicrobial’ category,
but the ﬁnal inclusion into DAMPD requires checking by
a domain expert. DAMPD will be updated regularly on a
bi-monthly basis. In the near feature we intend to add
text-mining capabilities to identify potential AMPs from
texts that possibly are not yet annotated as AMPs. We
believe that our DAMPD will be a useful resource for
researchers in this domain.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online:
Supplementary table S1.
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